Zim Corp (ZIMCF)
0.00
USD |
OTCM |
May 03, 16:00
Zim Max Drawdown (5Y): 99.93% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.93% |
| March 31, 2024 | 99.93% |
| February 29, 2024 | 99.93% |
| January 31, 2024 | 99.93% |
| December 31, 2023 | 99.93% |
| November 30, 2023 | 99.93% |
| October 31, 2023 | 99.93% |
| September 30, 2023 | 99.93% |
| August 31, 2023 | 99.93% |
| July 31, 2023 | 99.93% |
| June 30, 2023 | 99.93% |
| May 31, 2023 | 99.93% |
| April 30, 2023 | 99.93% |
| March 31, 2023 | 99.93% |
| February 28, 2023 | 99.93% |
| January 31, 2023 | 97.83% |
| December 31, 2022 | 97.83% |
| November 30, 2022 | 97.83% |
| October 31, 2022 | 97.83% |
| September 30, 2022 | 97.97% |
| August 31, 2022 | 97.97% |
| July 31, 2022 | 98.17% |
| June 30, 2022 | 98.17% |
| May 31, 2022 | 98.17% |
| April 30, 2022 | 98.17% |
| Date | Value |
|---|---|
| March 31, 2022 | 98.17% |
| February 28, 2022 | 98.17% |
| January 31, 2022 | 98.50% |
| December 31, 2021 | 98.50% |
| November 30, 2021 | 99.12% |
| October 31, 2021 | 99.12% |
| September 30, 2021 | 99.12% |
| August 31, 2021 | 99.12% |
| July 31, 2021 | 99.12% |
| June 30, 2021 | 99.12% |
| May 31, 2021 | 99.12% |
| April 30, 2021 | 99.12% |
| March 31, 2021 | 99.12% |
| February 28, 2021 | 99.12% |
| January 31, 2021 | 99.12% |
| December 31, 2020 | 99.12% |
| November 30, 2020 | 99.12% |
| October 31, 2020 | 99.12% |
| September 30, 2020 | 99.12% |
| August 31, 2020 | 99.12% |
| July 31, 2020 | 99.12% |
| June 30, 2020 | 99.12% |
| May 31, 2020 | 99.12% |
| April 30, 2020 | 99.12% |
| March 31, 2020 | 99.12% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.83%
Minimum
Oct 2022
99.93%
Maximum
Feb 2023
99.08%
Average
99.12%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| Acasti Pharma Inc | 98.73% |
| Aurinia Pharmaceuticals Inc | 87.58% |
| Edesa Biotech Inc | 99.58% |
| Lexaria Bioscience Corp | 98.90% |
| Liminal Biosciences Inc (DELISTED) | -- |